当前位置: »论坛 › 科研专区 › 文献互助› Abstract TH174: Efficacy and Safety of PCSK9 Inhibit ...

[AHA] Abstract TH174: Efficacy and Safety of PCSK9 Inhibitors versus Bempedoic Acid in Reducing LDL and Cardiovascular Risk in Patients with Dyslipidemia: a Systematic Review of Randomized Controlled Trials.

求助已关闭

bella0823 发表于 7 天前 | 显示全部楼层 |阅读模式

悬赏10积分

期刊：Hypertension

文献作者：RAM Ramamoorthy; Nitin Bhawnani; Prince Saha; Rashi bilgaiyan; Rahul Falodia

出版日期：2025-9-

DOI号：10.1161/hyp.82.suppl_1.th174

文献链接：https://doi.org/10.1161/hyp.82.suppl_1.th174

当前文献来源于 Ovid Technologies (Wolters Kluwer Health)。

备注信息：

使用道具捐赠获取积分应助有误反馈

全部回复0 显示全部楼层

发表回复

bella0823 Lv.4

VIP会员

发布
回复
积分
1150

同分类求助

30 METTL7B Mitigates Hypertension and Vascular Remodeling

[AHA] Abstract TH174: Efficacy and Safety of PCSK9 Inhibitors versus Bempedoic Acid in Reducing LDL and Cardiovascular Risk in Patients with Dyslipidemia: a Systematic Review of Randomized Controlled Trials.

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AHA] Abstract TH174: Efficacy and Safety of PCSK9 Inhibitors versus Bempedoic Acid in Reducing LDL and Cardiovascular Risk in Patients with Dyslipidemia: a Systematic Review of Randomized Controlled Trials. 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AHA] Abstract TH174: Efficacy and Safety of PCSK9 Inhibitors versus Bempedoic Acid in Reducing LDL and Cardiovascular Risk in Patients with Dyslipidemia: a Systematic Review of Randomized Controlled Trials.